V K Kawai1, R T Levinson2, A Adefurin1,3, D Kurnik1,4,5, S P Collier6, D Conway6, C M Stein1. 1. Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. 2. Vanderbilt Genetics Institute, Vanderbilt University School of Medicine, Nashville, TN, USA. 3. Department of Internal Medicine, Meharry Medical College, Nashville, TN, USA. 4. Clinical Pharmacology Unit, Rambam Medical Center, Haifa, Israel. 5. Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel. 6. Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.
Abstract
OBJECTIVE: Gestational diabetes (GDM) is characterized by maternal glucose intolerance that manifests during pregnancy. Because GDM resembles type 2 diabetes (T2DM), shared genetic predisposition is likely but has not been established. We tested the hypothesis that a genetic risk score (GRS) that included variants known to be associated with T2DM is associated with GDM. STUDY DESIGN: We conducted a case-control study using the Vanderbilt Medical Center biobank (BioVU) and calculated a simple-count GRS using 34 variants previously associated with T2DM or fasting glucose in the general population, or with GDM or glucose intolerance in pregnancy. We assessed the association of the GRS with GDM adjusting for maternal age, parity, and body mass index (BMI) and calculated the area under the curve for the receiver-operating characteristic curve (c-statistic). STUDY POPULATION: Among Caucasian women, we identified 458 cases of GDM and 1538 pregnant controls with normal glucose tolerance. RESULTS: Cases of GDM had a higher number of risk alleles compared to controls (38.9±4.0 vs 37.4±4.0 risk alleles, P=1.6×10-11 ). The GRS was significantly associated with GDM; the adjusted odds ratio associated with each additional risk allele was 1.10 (95% CI: 1.07-1.13, P=6×10-11 ). Clinical variables predicted the risk of GDM (c-statistic 0.67, 95% CI: 0.64-0.70), and adding the GRS modestly improved prediction (0.70, 95% CI: 0.67-0.73). CONCLUSIONS: Among Caucasian women, a GRS that included common T2DM genetic risk variants was associated with increased risk of GDM but showed limited utility in the identification of GDM cases.
OBJECTIVE:Gestational diabetes (GDM) is characterized by maternal glucose intolerance that manifests during pregnancy. Because GDM resembles type 2 diabetes (T2DM), shared genetic predisposition is likely but has not been established. We tested the hypothesis that a genetic risk score (GRS) that included variants known to be associated with T2DM is associated with GDM. STUDY DESIGN: We conducted a case-control study using the Vanderbilt Medical Center biobank (BioVU) and calculated a simple-count GRS using 34 variants previously associated with T2DM or fasting glucose in the general population, or with GDM or glucose intolerance in pregnancy. We assessed the association of the GRS with GDM adjusting for maternal age, parity, and body mass index (BMI) and calculated the area under the curve for the receiver-operating characteristic curve (c-statistic). STUDY POPULATION: Among Caucasian women, we identified 458 cases of GDM and 1538 pregnant controls with normal glucose tolerance. RESULTS: Cases of GDM had a higher number of risk alleles compared to controls (38.9±4.0 vs 37.4±4.0 risk alleles, P=1.6×10-11 ). The GRS was significantly associated with GDM; the adjusted odds ratio associated with each additional risk allele was 1.10 (95% CI: 1.07-1.13, P=6×10-11 ). Clinical variables predicted the risk of GDM (c-statistic 0.67, 95% CI: 0.64-0.70), and adding the GRS modestly improved prediction (0.70, 95% CI: 0.67-0.73). CONCLUSIONS: Among Caucasian women, a GRS that included common T2DM genetic risk variants was associated with increased risk of GDM but showed limited utility in the identification of GDM cases.
Authors: Hebe N Gouda; Gurdeep S Sagoo; Anne-Helen Harding; Jan Yates; Manjinder S Sandhu; Julian P T Higgins Journal: Am J Epidemiol Date: 2010-02-23 Impact factor: 4.897
Authors: S S Deeb; L Fajas; M Nemoto; J Pihlajamäki; L Mykkänen; J Kuusisto; M Laakso; W Fujimoto; J Auwerx Journal: Nat Genet Date: 1998-11 Impact factor: 38.330
Authors: Vivian K Kawai; Samuel K Nwosu; Daniel Kurnik; Frank E Harrell; C Michael Stein Journal: Obesity (Silver Spring) Date: 2019-05-22 Impact factor: 5.002
Authors: Natalia Pervjakova; Gunn-Helen Moen; Maria-Carolina Borges; Teresa Ferreira; James P Cook; Catherine Allard; Robin N Beaumont; Mickaël Canouil; Gad Hatem; Anni Heiskala; Anni Joensuu; Ville Karhunen; Soo Heon Kwak; Frederick T J Lin; Jun Liu; Sheryl Rifas-Shiman; Claudia H Tam; Wing Hung Tam; Gudmar Thorleifsson; Toby Andrew; Juha Auvinen; Bishwajit Bhowmik; Amélie Bonnefond; Fabien Delahaye; Ayse Demirkan; Philippe Froguel; Kadri Haller-Kikkatalo; Hildur Hardardottir; Sandra Hummel; Akhtar Hussain; Eero Kajantie; Elina Keikkala; Amna Khamis; Jari Lahti; Tove Lekva; Sanna Mustaniemi; Christine Sommer; Aili Tagoma; Evangelia Tzala; Raivo Uibo; Marja Vääräsmäki; Pia M Villa; Kåre I Birkeland; Luigi Bouchard; Cornelia M Duijn; Sarah Finer; Leif Groop; Esa Hämäläinen; Geoffrey M Hayes; Graham A Hitman; Hak C Jang; Marjo-Riitta Järvelin; Anne Karen Jenum; Hannele Laivuori; Ronald C Ma; Olle Melander; Emily Oken; Kyong Soo Park; Patrice Perron; Rashmi B Prasad; Elisabeth Qvigstad; Sylvain Sebert; Kari Stefansson; Valgerdur Steinthorsdottir; Tiinamaija Tuomi; Marie-France Hivert; Paul W Franks; Mark I McCarthy; Cecilia M Lindgren; Rachel M Freathy; Deborah A Lawlor; Andrew P Morris; Reedik Mägi Journal: Hum Mol Genet Date: 2022-09-29 Impact factor: 5.121
Authors: Vivian K Kawai; Rebecca T Levinson; Abiodun Adefurin; Daniel Kurnik; Sarah P Collier; Douglas Conway; Charles Michael Stein Journal: Pharmacogenomics Date: 2017-10-04 Impact factor: 2.533
Authors: Camille E Powe; Michael Nodzenski; Octavious Talbot; Catherine Allard; Catherine Briggs; Marysa V Leya; Patrice Perron; Luigi Bouchard; Jose C Florez; Denise M Scholtens; William L Lowe; Marie-France Hivert Journal: Diabetes Date: 2018-09-26 Impact factor: 9.461